Clinical characteristics and immunosuppressive treatment of patients according to pathology groups.</p
<p>Clinical characteristics for patients submitted to analyses of plasma and tissue.</p
Clinicopathological characteristics and proportion of PD-1+ leukocytes, PD-L1+ leukocytes and PD-L1+...
Characteristics of patients based on pathological architectural subgroups (n = 382).</p
<p>Clinical characteristics of the patients according to pathological findings.</p
Socio-demographic and life style characteristics of patients according to pathology groups.</p
Clinical characteristics of patients included in the study based on antiviral treatment.</p
<p>Sociodemographic and clinical characteristics of the patient and control groups.</p
<p>Clinical, demographic and laboratory characteristics of patients by diagnostic group.</p
<p>SC group, surgery with chemotherapy group; S group, surgery without chemotherapy group.</p><p>Pat...
<p>Clinico-pathological characteristics of the patients analyzed in this study.</p
<p>Demographic and clinical characteristics of the patient groups under study.</p
<p>Clinicopathologic and treatment characteristics of patients undergoing RHC therapy.</p
Clinicopathological characteristics of the patients involved in this study (n = 95).</p
Clinical characteristics of the clopidogrel and ticagrelor or prasugrel groups.</p
Characteristics of the major clinical subgroups and their healthy control counterparts.</p
<p>Clinical characteristics for patients submitted to analyses of plasma and tissue.</p
Clinicopathological characteristics and proportion of PD-1+ leukocytes, PD-L1+ leukocytes and PD-L1+...
Characteristics of patients based on pathological architectural subgroups (n = 382).</p
<p>Clinical characteristics of the patients according to pathological findings.</p
Socio-demographic and life style characteristics of patients according to pathology groups.</p
Clinical characteristics of patients included in the study based on antiviral treatment.</p
<p>Sociodemographic and clinical characteristics of the patient and control groups.</p
<p>Clinical, demographic and laboratory characteristics of patients by diagnostic group.</p
<p>SC group, surgery with chemotherapy group; S group, surgery without chemotherapy group.</p><p>Pat...
<p>Clinico-pathological characteristics of the patients analyzed in this study.</p
<p>Demographic and clinical characteristics of the patient groups under study.</p
<p>Clinicopathologic and treatment characteristics of patients undergoing RHC therapy.</p
Clinicopathological characteristics of the patients involved in this study (n = 95).</p
Clinical characteristics of the clopidogrel and ticagrelor or prasugrel groups.</p
Characteristics of the major clinical subgroups and their healthy control counterparts.</p
<p>Clinical characteristics for patients submitted to analyses of plasma and tissue.</p
Clinicopathological characteristics and proportion of PD-1+ leukocytes, PD-L1+ leukocytes and PD-L1+...
Characteristics of patients based on pathological architectural subgroups (n = 382).</p